Will AI Scientists solve drug R&D, or just make it faster?
Hosted by Owkin & AWS
Join us for an invite-only panel discussion and networking event exploring one of the most important questions facing the future of drug R&D: Will AI Scientists truly solve the underlying challenges that have constrained drug discovery and development for decades, or will they simply make existing processes faster and more efficient?
What’s on the agenda?
6:30 PM — Arrival & Welcome
7:00–7:45 PM — Expert Panel: Will AI Scientists solve Drug R&D, or simply make it faster?
8:00–10:00 PM — Networking Reception with drinks & canapés
Moderator: Pascal Weinberger, Co-CEO, Owkin
Panelists
Michelle Chen, PhD, President & CEO, Form BIO
Vivek Natarajan, AI Researcher, Google
Sam Rodrigues, Co-Founder and CEO, FutureHouse and Edison Scientific
David Yang, Partner, Lux Capital
James Zou, Associate Professor of Biomedical Data Science, Stanford University
More panelists to be announced soon.
Attendance is limited and available by invitation only.